Angiotensin-(1-7) abolishes AGE-induced cellular hypertrophy and myofibroblast transformation via inhibition of ERK1/2

Cellular Signalling

Volumn 26, Issue 12, 2014, Pages 3027-3035

  Alzayadneh, Ebaa M ^a   Chappell, Mark C ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Advanced glycation endproducts; Angiotensin; EMT; ERK1 2; TGF B

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALBUMINOID; ALISKIREN; ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN[1-7]; LISINOPRIL; LOSARTAN; METHYLGLYOXAL; METHYLGLYOXAL MODIFIED ALBUMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PD 58059; PROTEIN KINASE INHIBITOR; SB 525334; UNCLASSIFIED DRUG; ANGIOTENSIN I; ANGIOTENSIN I (1-7); MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE FRAGMENT; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL HYPERTROPHY; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG PROTEIN BINDING; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPERTROPHY; IMMUNOHISTOCHEMISTRY; KIDNEY EPITHELIUM; METABOLITE; MYOFIBROBLAST; PEPTIDE ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PATHOLOGY; PHOSPHORYLATION; RAT;

ALBUMINS; ANGIOTENSIN I; ANIMALS; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERTROPHY; MYOFIBROBLASTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84908265737     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2014.09.010     Document Type: Article

References (52)

1. Alzayadneh E.M., Chappell M.C. J. Renin-Angiotensin-Aldosterone Syst. 2014, Epub June 24.
2. Benter I.F., Yousif M.H., Dhaunsi G.S., Kaur J., Chappell M.C., Diz D.I. Am. J. Nephrol. 2008, 28:25-33.
3. Benter I.F., Yousif M.H.M., Anim J.T., Cojocel C., Diz D.I. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H684-H691.
4. Brenner B.M., Cooper M.E., de Z.D., Keane W.F., Mitch W.E., Parving H.H., Remuzzi G., Snapinn S.M., Zhang Z., Shahinfar S. N. Engl. J. Med. 2001, 345:861-869.
5. Burns W.C., Velkoska E., Dean R., Burrell L.M., Thomas M.C. Am. J. Physiol. Ren. Physiol. 2010, 299:F585-F593.
6. Burns W.C., Twigg S.M., Forbes J.M., Pete J., Tikellis C., Thallas-Bonke V., Thomas M.C., Cooper M.E., Kantharidis P. J. Am. Soc. Nephrol. 2006, 17:2484-2494.
7. Cao W., Xu J., Zhou Z.M., Wang G.B., Hou F.F., Nie J. Antioxid. Redox Signal. 2013, 18:19-35.
8. Castelo-Branco R.C., Leite-Delova D.C., de Mello-Aires M. Am. J. Physiol. Ren. Physiol. 2013, 304:F1258-F1265.
9. Chappell M.C. Hypertension 2007, 50:596-599.
10. Chappell M.C., Marshall A.C., Alzayadneh E.M., Shaltout H.A., Diz D.I. Front. Endocrinol. (lausanne) 2014, 4:1-13.
11. Chen J., Chen J.K., Neilson E.G., Harris R.C. J. Am. Soc. Nephrol. 2006, 17:1615-1623.
12. Chou C.H., Chuang L.Y., Lu C.Y., Guh J.Y. Mol. Cell. Endocrinol. 2013, 366:21-30.
13. Christiane R., Tzvetanka B., Sybille F., Martin F., Gunter W. Nephrol. Dial. Transplant. 2008, 23:2179.
14. Fan J.M., Ng Y.Y., Hill P.A., Nikolic-Paterson D.J., Mu W., Atkins R.C., Lan H.Y. Kidney Int. 1999, 56:1455-1467.
15. Forbes J.M., Cooper M.E., Oldfield M.D., Thomas M.C. J. Am. Soc. Nephrol. 2003, 14:S254-S258.
16. Fujita H., Omori S., Ishikura K., Hida M., Awazu M. Am. J. Physiol. Ren. Physiol. 2003, 286:F120-F126.
17. Gallagher P.E., Ferrario C.M., Tallant E.A. Am. J. Physiol. Cell Physiol. 2008, 295:C1169-C1174.
18. Gava E., Samad-Zadeh A., Zimpelmann J., Bahramifarid N., Kitten G.T., Santos R.A., Touyz R.M., Burns K.D. Nephrol. Dial. Transplant. 2009, 24:1766-1773.
19. Giani J.F., Munoz M.C., Pons R.A., Cao G., Toblli J.E., Turyn D., Dominici F.P. Am. J. Physiol. Ren. Physiol. 2011, 300:F272-F282.
20. Gross M.L., El-Shakmak A., Szabo A., Koch A., Kuhlmann A., Munter K., Ritz E., Amann K. Diabetologia 2003, 46:856-868.
21. Heringer-Walther S., Gembardt F., Perschel F.H., Katz N., Schultheiss H.P., Walther T. Eur. J. Pharmacol. 2012, 689:147-153.
22. Houillier P., Chambrey R., Achard J.M., Froissart M., Poggioli J., Paillard M. Kidney Int. 1996, 50:1496-1505.
23. Huang J.S., Chuang L.Y., Guh J.Y., Yang Y.L., Hsu M.S. Toxicol. Appl. Pharmacol. 2008, 233:220-226.
24. Ishibashi Y., Matsui T., Yamagishi S. Horm. Metab. Res. 2014, 46:379-383.
25. Jinde K., Nikolic-Paterson D.J., Huang X.R., Sakai H., Kurokawa K., Atkins R.C., Lan H.Y. Am. J. Kidney Dis. 2001, 38:761-769.
26. Kriz W., Kaissling B., Le H.M. J. Clin. Invest. 2011, 121:468-474.
27. Lee M.K., Pardoux C., Hall M.C., Lee P.S., Warburton D., Qing J., Smith S.M., Derynck R. EMBO J. 2007, 26:3957-3967.
28. Li J.H., Huang X.R., Zhu H.J., Oldfield M., Cooper M., Truong L.D., Johnson R.J., Lan H.Y. FASEB J. 2004, 18:176-178.
29. Li J.H., Wang W., Huang X.R., Oldfield M., Schmidt A.M., Cooper M.E., Lan H.Y. Am. J. Pathol. 2004, 164:1389-1397.
30. Liu G.C., Oudit G.Y., Fang F., Zhou J., Scholey J.W. Am. J. Physiol. Ren. Physiol. 2012, 302:F784-F790.
31. Makita Z., Radoff S., Rayfield E.J., Yang Z., Skolnik E., Delaney V., Friedman E.A., Cerami A., Vlassara H. N. Engl. J. Med. 1991, 325:2836-2842.
32. Mann J.F., Schmieder R.E., McQueen M., Dyal L., Schumacher H., Pogue J., Wang X., Maggioni A., Budaj A., Chaithiraphan S., Dickstein K., Keltai M., Metsarinne K., Oto A., Parkhomenko A., Piegas L.S., Svendsen T.L., Teo K.K., Yusuf S. Lancet 2008, 372:547-553.
33. Marshall A.C., Pirro N.T., Rose J.C., Diz D.I., Chappell M.C. J. Neurochem. 2014, 30:313-323.
34. McCollum L.T., Gallagher P.E., Ann Tallant E. Am. J. Physiol. Heart Circ. Physiol. 2012, 302:H801-H810.
35. Moon J.Y., Tanimoto M., Gohda T., Hagiwara S., Yamazaki T., Ohara I., Murakoshi M., Aoki T., Ishikawa Y., Lee S.H., Jeong K.H., Lee T.W., Ihm C.G., Lim S.J., Tomino Y. Am. J. Physiol. Ren. Physiol. 2011, 300:F1271-F1282.
36. Oldfield M.D., Bach L.A., Forbes J.M., Nikolic-Paterson D., McRobert A., Thallas V., Atkins R.C., Osicka T., Jerums G., Cooper M.E. J. Clin. Invest. 2001, 108:1853-1863.
37. Parving H.H., Brenner B.M., McMurray J.J., de Zeeuw D., Haffner S.M., Solomon S.D., Chaturvedi N., Ghadanfar M., Weissbach N., Xiang Z., Armbrecht J., Pfeffer M.A. Nephrol. Dial. Transplant. 2009, 24:1663-1671.
38. Rasch R., Norgaard J.O. Diabetologia 1983, 25:280-287.
39. Ruggenenti P., Cravedi P., Remuzzi G. Nat. Rev. Nephrol. 2010, 6:319-330.
40. Santos R.A. Hypertension 2014, 63:1138-1147.
41. Seyer-Hansen K., Hansen J., Gundersen H.J. Diabetologia 1980, 18:501-505.
42. Shaltout H.A., Westwood B., Averill D.B., Ferrario C.M., Figueroa J., Diz D.I., Rose J.C., Chappell M.C. Am. J. Physiol. Ren. Physiol. 2006, 292:F82-F91.
43. Shao Y., He M., Zhou L., Yao T., Huang Y., Lu L.M. Acta Pharmacol. Sin. 2008, 29:829-837.
44. Soulis-Liparota T., Cooper M.E., Dunlop M., Jerums G. Diabetologia 1995, 38:387-394.
45. Tanji N., Markowitz G.S., Fu C., Kislinger T., Taguchi A., Pischetsrieder M., Stern D., Schmidt A.M., D'Agati V.D. J. Am. Soc. Nephrol. 2000, 11:1656-1666.
46. Thomas M.C., Tikellis C., Burns W.M., Bialkowski K., Cao Z., Coughlan M.T., Jandeleit-Dahm K., Cooper M.E., Forbes J.M. J. Am. Soc. Nephrol. 2005, 16:2976-2984.
47. Tikellis C., Bialkowski K., Pete J., Sheehy K., Su Q., Johnston C., Cooper M., Thomas M. Diabetes 2008, 57:1018-1025.
48. Westwood M.E., Argirov O.K., Abordo E.A., Thornalley P.J. Biochim. Biophys. Acta 1997, 1356:84-94.
49. Yang J., Liu Y. Am. J. Pathol. 2001, 159:1465-1475.
50. Zhou L., Xue H., Wang Z., Ni J., Yao T., Huang Y., Yu C., Lu L. Life Sci. 2012, 90:454-462.
51. Zhou L., Xue H., Yuan P., Ni J., Yu C., Huang Y., Lu L.M. Clin. Exp. Pharmacol. Physiol. 2010, 37:e152-e157.
52. Zimmerman D., Burns K.D. Clin. Sci. (Lond.) 2012, 123:333-346.